We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Analytik Jena Develops Innovative Technology

Read time: Less than a minute

After a two year period of development Analytik Jena has launched an innovative technology to enrich and isolate free-circulating DNA. Free-circulating DNA occurs in plasma, serum, and urine, among other things, but only in small fragments and very low concentrations.

In order to isolate them, large sample volumes and large quantities of reagents had been needed until now. The kit developed by the Analytik Jena subsidiary AJ Innuscreen GmbH in Berlin is based on polymer-mediated enrichment (PME) technology.

The cell-free DNA of the sample is combined with a polymer and then concentrated. The resulting DNA-polymer complex can be processed by means of a simple DNA extraction method.

With this new technology, Analytik Jena AG is opening up new diagnostic possibilities with enormous potential and various applications. The new enrichment and isolation method is for example used in tumor diagnostics. Circulating cell-free DNA is also gaining increasing significance in pre-natal diagnostics, the diagnosis of metabolic diseases, or sports medicine.

"With far fewer steps, the process is efficient, can be performed very quickly, and reduces the amount of reagents that must be used. Thus isolate free-circulating DNA is provided much easier," said Alexander Berka, General Manager of the Life Science business unit at Analytik Jena AG.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.